JP2001151700A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001151700A5 JP2001151700A5 JP1999330020A JP33002099A JP2001151700A5 JP 2001151700 A5 JP2001151700 A5 JP 2001151700A5 JP 1999330020 A JP1999330020 A JP 1999330020A JP 33002099 A JP33002099 A JP 33002099A JP 2001151700 A5 JP2001151700 A5 JP 2001151700A5
- Authority
- JP
- Japan
- Prior art keywords
- inhibitor
- antioxidant
- lymphoid
- neoplastic disease
- pyrrolidinedithiocarbamate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- FAWLNURBQMTKEB-URDPEVQOSA-N 213546-53-3 Chemical compound N([C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N1[C@@H](CCC1)C(O)=O)C(C)C)C(C)C)C(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(C)C FAWLNURBQMTKEB-URDPEVQOSA-N 0.000 description 4
- VSWDORGPIHIGNW-UHFFFAOYSA-N Pyrrolidine dithiocarbamic acid Chemical group SC(=S)N1CCCC1 VSWDORGPIHIGNW-UHFFFAOYSA-N 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000017128 negative regulation of NF-kappaB transcription factor activity Effects 0.000 description 4
- 230000001613 neoplastic effect Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 208000009746 Adult T-Cell Leukemia-Lymphoma Diseases 0.000 description 1
- 206010001413 Adult T-cell lymphoma/leukaemia Diseases 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- 208000019420 lymphoid neoplasm Diseases 0.000 description 1
- 230000004565 tumor cell growth Effects 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP33002099A JP2001151700A (ja) | 1999-11-19 | 1999-11-19 | リンパ系腫瘍性疾患治療剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP33002099A JP2001151700A (ja) | 1999-11-19 | 1999-11-19 | リンパ系腫瘍性疾患治療剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001151700A JP2001151700A (ja) | 2001-06-05 |
| JP2001151700A5 true JP2001151700A5 (fr) | 2007-05-17 |
Family
ID=18227886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP33002099A Pending JP2001151700A (ja) | 1999-11-19 | 1999-11-19 | リンパ系腫瘍性疾患治療剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2001151700A (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008247797A (ja) * | 2007-03-30 | 2008-10-16 | Univ Of Miyazaki | 成人ｔ細胞性白血病の予防剤、治療剤、及びその医薬品組成物 |
-
1999
- 1999-11-19 JP JP33002099A patent/JP2001151700A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1378240A3 (fr) | Compositions pharmaceutiques à base d'arsenic pour le traitement du myelome multiple | |
| CA2356300A1 (fr) | Derives 3-azabicyclo[3.1.0]hexane utiles en therapie | |
| MX9602683A (es) | Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas. | |
| WO2002080890A3 (fr) | Composition pharmaceutique de jasmonate pour le traitement du cancer | |
| GEP20053688B (en) | Substituted-Triazolopyrimidines as Anticancer Agents | |
| ZA200201511B (en) | 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents. | |
| MXPA02001497A (es) | Derivados de 3-(5)-ureido-pirazol, procedimiento para su preparacion y sus uso como agentes antitumorales. | |
| IL151373A0 (en) | Pharmaceutical compositions for treating cancer comprising a 1,4-benzodiazepine derivative | |
| WO2001066103A3 (fr) | Formulation et methode de traitement des neoplasmes par inhalation | |
| WO2000016762A3 (fr) | Procede pour reduire la dependance a la nicotine | |
| NZ334124A (en) | Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease | |
| CA2180535A1 (fr) | Procede de traitement du psoriasis par omeprazole ou autres composes apparentes | |
| SE0104248D0 (sv) | Method of treatment | |
| MY119375A (en) | Treatment of tinnitus using neuroprotective agents | |
| WO2001051473A8 (fr) | 1,2-diaralbenzimidazoles utilises pour traiter des affections associees a une activation de la microglie | |
| AU5801996A (en) | Use of 1,2,4-triazole derivatives for the manufacture of a medicament for the treatment of cancers | |
| AU5651799A (en) | Remedies for photochemotherapy | |
| MXPA01011606A (es) | Terapia anti-inflamatoria para infeccion mediada por inflamacion. | |
| AU6442900A (en) | Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments | |
| IL143985A0 (en) | New use of melagatran | |
| IL165086A0 (en) | Cyanoguanidine prodrugs | |
| GB9907571D0 (en) | Compounds | |
| AU3913900A (en) | Radioenhanced cancer treatment using orally administered camptothecin derivatives | |
| WO1998003519A3 (fr) | Nouveaux complexes de bis-platine comportant des ligands polyamine et utilises en tant qu'agents antitumoraux | |
| WO1998033470A3 (fr) | Perylenequinones substituees destinees a la therapie photodynamique |